Edmond de Rothschild Holding’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
13,366,200
-8,488,980
| -39% | -$10.5M | 0.26% | 93 |
|
|
2025
Q1 | $25.8M | Buy |
21,855,180
+508,700
| +2% | +$600K | 0.46% | 60 |
|
|
2024
Q4 | $39.1M | Buy |
21,346,480
+1,038,600
| +5% | +$1.9M | 0.67% | 35 |
|
|
2024
Q3 | $34.5M | Buy |
20,307,880
+3,571,460
| +21% | +$6.07M | 0.56% | 45 |
|
|
2024
Q2 | $22.9M | Buy |
16,736,420
+6,229,133
| +59% | +$8.53M | 0.39% | 66 |
|
|
2024
Q1 | $39.4M | Buy |
10,507,287
+9,511,787
| +955% | +$35.7M | 0.66% | 42 |
|
|
2023
Q4 | $9.77M | Buy |
995,500
+188,600
| +23% | +$1.85M | 0.17% | 131 |
|
|
2023
Q3 | $6.74M | Buy |
806,900
+379,400
| +89% | +$3.17M | 0.14% | 141 |
|
|
2023
Q2 | $5.69M | Buy |
+427,500
| New | +$5.69M | 0.11% | 162 |
|
|
2017
Q2 | – | Sell |
-1,100
| Closed | -$6K | – | 823 |
|
|
2017
Q1 | $6K | Buy |
+1,100
| New | +$6K | ﹤0.01% | 769 |
|
|
2016
Q4 | – | Sell |
-5,560
| Closed | -$50K | – | 849 |
|
|
2016
Q3 | $50K | Buy |
+5,560
| New | +$50K | ﹤0.01% | 651 |
|
|
2015
Q4 | – | Sell |
-12,000
| Closed | -$44K | – | 852 |
|
|
2015
Q3 | $44K | Sell |
12,000
-14,000
| -54% | -$51.3K | ﹤0.01% | 629 |
|
|
2015
Q2 | $150K | Buy |
+26,000
| New | +$150K | ﹤0.01% | 515 |
|